Year |
Citation |
Score |
2016 |
Fielden MR, Dean C, Black K, Sawant SG, Subramanian R, Tomlinson JE, Walter S, Zimmermann C, Griggs MW, McKeon ME, Lewis EM, Beevers C, Pyrah I. Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism. International Journal of Toxicology. PMID 26941242 DOI: 10.1177/1091581816633407 |
0.96 |
|
2015 |
Fielden MR, Werner J, Jamison JA, Coppi A, Hickman D, Dunn RT, Trueblood E, Zhou L, Afshari CA, Lightfoot-Dunn R. Retinal Toxicity Induced by a Novel β-secretase Inhibitor in the Sprague-Dawley Rat. Toxicologic Pathology. 43: 581-92. PMID 25361751 DOI: 10.1177/0192623314553804 |
0.96 |
|
2014 |
Sawant SG, Fielden MR, Black KA. Evaluation of genotoxicity testing of FDA approved large molecule therapeutics. Regulatory Toxicology and Pharmacology : Rtp. 70: 87-97. PMID 24932799 DOI: 10.1016/j.yrtph.2014.06.005 |
0.96 |
|
2013 |
Bourbeau MP, Siegmund A, Allen JG, Shu H, Fotsch C, Bartberger MD, Kim KW, Komorowski R, Graham M, Busby J, Wang M, Meyer J, Xu Y, Salyers K, Fielden M, et al. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase. Journal of Medicinal Chemistry. 56: 10132-41. PMID 24294923 DOI: 10.1021/jm401601s |
0.96 |
|
2013 |
Garrido R, Zabka TS, Tao J, Fielden MR, Fretland AJ, Albassam M. Authors' response to letter to the editor on "image cytometry protocols". The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 61: 761-2. PMID 24084868 DOI: 10.1369/0022155413502057 |
0.96 |
|
2011 |
Fielden MR, Adai A, Dunn RT, Olaharski A, Searfoss G, Sina J, Aubrecht J, Boitier E, Nioi P, Auerbach S, Jacobson-Kram D, Raghavan N, Yang Y, Kincaid A, Sherlock J, et al. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat. Toxicological Sciences : An Official Journal of the Society of Toxicology. 124: 54-74. PMID 21813463 DOI: 10.1093/toxsci/kfr202 |
0.96 |
|
2011 |
Zabka TS, Fielden MR, Garrido R, Tao J, Fretland AJ, Fretland JL, Albassam MA, Singer T, Kolaja KL. Characterization of xenobiotic-induced hepatocellular enzyme induction in rats: anticipated thyroid effects and unique pituitary gland findings. Toxicologic Pathology. 39: 664-77. PMID 21551028 DOI: 10.1177/0192623311406934 |
0.96 |
|
2011 |
Fielden MR. Application of Genomics for Predicting and Understanding the Mode of Action for Nongenotoxic Carcinogens Applications of Toxicogenomics in Safety Evaluation and Risk Assessment. 99-116. DOI: 10.1002/9781118001042.ch6 |
0.96 |
|
2010 |
Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nature Biotechnology. 28: 827-38. PMID 20676074 DOI: 10.1038/nbt.1665 |
0.96 |
|
2010 |
Mikaelian I, Buness A, de Vera-Mudry MC, Kanwal C, Coluccio D, Rasmussen E, Char HW, Carvajal V, Hilton H, Funk J, Hoflack JC, Fielden M, Herting F, Dunn M, Suter-Dick L. Primary endothelial damage is the mechanism of cardiotoxicity of tubulin-binding drugs. Toxicological Sciences : An Official Journal of the Society of Toxicology. 117: 144-51. PMID 20624997 DOI: 10.1093/toxsci/kfq189 |
0.96 |
|
2010 |
Fielden MR, Hassani M, Uppal H, Day-Lollini P, Button D, Martin RS, Garrido R, Liu X, Kolaja KL. Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft FüR Toxikologische Pathologie. 62: 607-13. PMID 19781924 DOI: 10.1016/j.etp.2009.08.009 |
0.96 |
|
2008 |
Natsoulis G, Pearson CI, Gollub J, P Eynon B, Ferng J, Nair R, Idury R, Lee MD, Fielden MR, Brennan RJ, Roter AH, Jarnagin K. The liver pharmacological and xenobiotic gene response repertoire. Molecular Systems Biology. 4: 175. PMID 18364709 DOI: 10.1038/msb.2008.9 |
0.96 |
|
2008 |
Fielden MR, Kolaja KL. The role of early in vivo toxicity testing in drug discovery toxicology. Expert Opinion On Drug Safety. 7: 107-10. PMID 18324874 DOI: 10.1517/14740338.7.2.107 |
0.96 |
|
2008 |
Wang EJ, Snyder RD, Fielden MR, Smith RJ, Gu YZ. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology. 246: 91-100. PMID 18289764 DOI: 10.1016/j.tox.2007.12.031 |
0.96 |
|
2008 |
Fielden MR, Nie A, McMillian M, Elangbam CS, Trela BA, Yang Y, Dunn RT, Dragan Y, Fransson-Stehen R, Bogdanffy M, Adams SP, Foster WR, Chen SJ, Rossi P, Kasper P, et al. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicological Sciences : An Official Journal of the Society of Toxicology. 103: 28-34. PMID 18281259 DOI: 10.1093/toxsci/kfn022 |
0.96 |
|
2007 |
Fielden MR, Brennan R, Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicological Sciences : An Official Journal of the Society of Toxicology. 99: 90-100. PMID 17557906 DOI: 10.1093/toxsci/kfm156 |
0.96 |
|
2007 |
Fielden MR, Halbert DN. Iconix Biosciences, Inc. Pharmacogenomics. 8: 401-5. PMID 17391077 DOI: 10.2217/14622416.8.4.401 |
0.96 |
|
2007 |
Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR. Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Molecular Pharmacology. 71: 1475-86. PMID 17327465 DOI: 10.1124/mol.106.032748 |
0.96 |
|
2006 |
Fielden MR, Kolaja KL. The state-of-the-art in predictive toxicogenomics. Current Opinion in Drug Discovery & Development. 9: 84-91. PMID 16445120 |
0.96 |
|
2005 |
Fielden MR, Eynon BP, Natsoulis G, Jarnagin K, Banas D, Kolaja KL. A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity. Toxicologic Pathology. 33: 675-83. PMID 16239200 DOI: 10.1080/01926230500321213 |
0.96 |
|
2005 |
Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, Brady L, Browne LJ, Calvin JT, Day GJ, Breckenridge N, Dunlea S, Eynon BP, Furness LM, Ferng J, ... Fielden MR, et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. Journal of Biotechnology. 119: 219-44. PMID 16005536 DOI: 10.1016/j.jbiotec.2005.03.022 |
0.96 |
|
2005 |
Fielden MR, Pearson C, Brennan R, Kolaja KL. Preclinical drug safety analysis by chemogenomic profiling in the liver. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 5: 161-71. PMID 15952870 DOI: 10.2165/00129785-200505030-00003 |
0.96 |
|
2004 |
Sun YV, Boverhof DR, Burgoon LD, Fielden MR, Zacharewski TR. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Research. 32: 4512-23. PMID 15328365 DOI: 10.1093/nar/gkh782 |
0.96 |
|
2003 |
Fielden MR, Samy SM, Chou KC, Zacharewski TR. Effect of human dietary exposure levels of genistein during gestation and lactation on long-term reproductive development and sperm quality in mice. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 41: 447-54. PMID 12615117 DOI: 10.1016/S0278-6915(02)00284-3 |
0.96 |
|
2002 |
Fielden MR, Halgren RG, Fong CJ, Staub C, Johnson L, Chou K, Zacharewski TR. Gestational and lactational exposure of male mice to diethylstilbestrol causes long-term effects on the testis, sperm fertilizing ability in vitro, and testicular gene expression. Endocrinology. 143: 3044-59. PMID 12130571 DOI: 10.1210/endo.143.8.8968 |
0.96 |
|
2002 |
Fielden MR, Fong CJ, Haslam SZ, Zacharewski TR. Normal mammary gland morphology in pubertal female mice following in utero and lactational exposure to genistein at levels comparable to human dietary exposure. Toxicology Letters. 133: 181-91. PMID 12119126 DOI: 10.1016/S0378-4274(02)00154-6 |
0.96 |
|
2002 |
Fielden MR, Halgren RG, Dere E, Zacharewski TR. GP3: GenePix post-processing program for automated analysis of raw microarray data. Bioinformatics (Oxford, England). 18: 771-3. PMID 12050078 |
0.96 |
|
2002 |
Fielden MR, Matthews JB, Fertuck KC, Halgren RG, Zacharewski TR. In silico approaches to mechanistic and predictive toxicology: an introduction to bioinformatics for toxicologists. Critical Reviews in Toxicology. 32: 67-112. PMID 11951993 DOI: 10.1080/20024091064183 |
0.96 |
|
2001 |
Fielden MR, Halgren RG, Tashiro CH, Yeo BR, Chittim B, Chou K, Zacharewski TR. Effects of gestational and lactational exposure to Aroclor 1242 on sperm quality and in vitro fertility in early adult and middle-aged mice. Reproductive Toxicology (Elmsford, N.Y.). 15: 281-92. PMID 11390173 DOI: 10.1016/S0890-6238(01)00129-0 |
0.96 |
|
2001 |
Fielden MR, Zacharewski TR. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 60: 6-10. PMID 11222867 DOI: 10.1093/toxsci/60.1.6 |
0.96 |
|
2001 |
Halgren RG, Fielden MR, Fong CJ, Zacharewski TR. Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones. Nucleic Acids Research. 29: 582-8. PMID 11139630 |
0.96 |
|
2000 |
Fielden MR, Wu ZF, Sinal CJ, Jury HH, Bend JR, Hammond GL, Zacharewski TR. Estrogen receptor- and aryl hydrocarbon receptor-mediated activities of a coal-tar creosote Environmental Toxicology and Chemistry. 19: 1262-1271. |
0.96 |
|
1998 |
Zacharewski TR, Meek MD, Clemons JH, Wu ZF, Fielden MR, Matthews JB. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicological Sciences : An Official Journal of the Society of Toxicology. 46: 282-93. PMID 10048131 DOI: 10.1006/toxs.1998.2505 |
0.96 |
|
1997 |
Fielden MR, Chen I, Chittim B, Safe SH, Zacharewski TR. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155). Environmental Health Perspectives. 105: 1238-48. PMID 9370515 |
0.96 |
|
Show low-probability matches. |